KRAS Mutation Analysis Treatment in India – Best Hospitals & Doctors

Learn about KRAS Mutation Analysis Treatment in India — how it works, who it is for, recovery timelines, and what to expect before and after surgery. Compare hospitals and doctors experienced in KRAS Mutation Analysis and request assistance for cost estimates or appointments.

Partner Hospitals

0 partner in India for this surgery

Specialist Doctors

3 Surgeons linked to this surgery

Treatment Cost

Approx INR 8 Thousand – 25 Thousand

About KRAS Mutation Analysis

KRAS Mutation Analysis is a specialized genetic test performed by Genetic Medicine specialists to detect specific mutations in the KRAS gene. This gene plays a critical role in cell growth and division. Mutations in KRAS are commonly found in several cancers, most notably colorectal, pancreatic, and non-small cell lung cancer. The analysis is typically performed on a tissue sample obtained from a tumor biopsy or surgical resection. Identifying a KRAS mutation provides crucial information for oncologists, as it can determine a patient's eligibility for targeted therapies, such as EGFR inhibitors, and helps predict treatment response and prognosis. This personalized approach is a cornerstone of modern precision oncology, guiding more effective and tailored treatment plans.

Key Highlights

Guides personalized, targeted cancer therapy decisions.Helps predict response to specific drugs like EGFR inhibitors.Provides critical prognostic information for several cancer types.Uses advanced molecular techniques for high accuracy.Enables a precision medicine approach to oncology care.

Who is this surgery for?

Diagnosis of metastatic colorectal cancer to guide anti-EGFR therapy.
Evaluation of advanced non-small cell lung cancer (NSCLC).
Diagnosis and management of pancreatic ductal adenocarcinoma.
Part of the molecular profiling for various solid tumors.
When standard chemotherapy has failed, to identify targeted options.
For patients being considered for clinical trials involving KRAS-targeted drugs.

How to prepare

Consultation with an oncologist or genetic counselor to discuss the test's purpose.
Provision of a formalin-fixed, paraffin-embedded (FFPE) tissue block or slides from a prior biopsy or surgery.
If a new biopsy is needed, standard pre-biopsy preparations (like fasting) may apply.
Informed consent process explaining the genetic nature of the test.
Insurance pre-authorization may be required.

Risks & possible complications

Risks are primarily associated with the tissue biopsy procedure (if a new sample is needed), such as bleeding, infection, or pain.
Potential for an inconclusive result if the tissue sample has insufficient tumor DNA.
Psychological impact of genetic information related to prognosis.
Possible insurance or privacy concerns regarding genetic data (handled under strict confidentiality).
No direct physical risks from the laboratory analysis itself.

Recovery & hospital stay

Recovery is from the biopsy procedure, not the genetic test. Patients can typically resume normal activities shortly after a needle biopsy.
Care for the biopsy site as instructed (e.g., keeping it clean and dry).
Results are usually available within 7-14 business days and will be discussed in a follow-up appointment with the oncologist.
The oncologist will explain the results and their implications for the treatment plan.
No specific lifestyle changes are required post-analysis.

Typical hospital stay: 0 days (outpatient for biopsy if needed)
Expected recovery time: 0-2 days (from biopsy procedure)

Frequently Asked Questions

If you are considering kras mutation analysis in India, these questions and answers can help you make a confident, informed decision.

＋ − Which hospitals are best for kras mutation analysis in India?

Top-rated hospitals in India with genetic medicine departments and experienced surgeons are ideal for this procedure. Use MediFyr to compare facilities, reviews, and doctor profiles before you decide.

＋ − How do I choose the right doctor for kras mutation analysis?

Look at the doctor’s years of experience, hospital association, patient reviews, and how often they perform kras mutation analysis. MediFyr helps you compare genetic medicines and book consultations online.

＋ − What factors affect the cost of kras mutation analysis?

The overall cost depends on hospital category, surgeon’s experience, room type, implant or device used (if any), length of stay, tests, and post-operative care. Our team can help you get cost estimates from multiple hospitals before you decide.

Get assistance for KRAS Mutation Analysis

Share a few details and our team will help you compare hospitals, understand costs, and schedule a consultation with the right specialist.

Real People Helping Real Patients!
Get Assistance.

Procedure cost in other countries

Here is an overview of how the estimated cost, hospital stay, and recovery time for kras mutation analysis compare across other countries where we have data.

Country	Estimated cost range	Typical stay	Recovery time	View details
India	INR 8 Thousand – 25 Thousand	0 days (outpatient for biopsy if needed)	~ 0-2 days (from biopsy procedure)	Know More
Turkey	TRY 28 Thousand – 87.5 Thousand	0 days (outpatient for biopsy if needed)	~ 0-2 days (from biopsy procedure)	Know More

PATIENT REVIEW

Angel Singh, a 58-year-old former school...

Angel Singh, a 58-year-old former school librarian, had always been health-conscious. Her world tilted when she developed a persistent cough and unexplained weight loss. A CT scan revealed a mass in her lung. After a biopsy confirmed stage IV non-small cell lung cancer (NSCLC), her oncologist, Dr. Mehta, recommended a KRAS mutation analysis. 'This test,' she explained, 'can tell us the specific 'driver' of your cancer and open doors to newer, targeted therapies.' The procedure itself was straightforward, a small piece of her biopsy tissue was sent to a specialized lab. The wait for results was agonizing; Angel felt like a statistic, her future hinging on a microscopic genetic typo. When the results came back positive for a KRAS G12C mutation, it was a bittersweet moment. It confirmed the aggressiveness of her disease, but it also made her eligible for a newly approved targeted drug called sotorasib. Starting the treatment, she experienced manageable side effects like fatigue. Six months later, follow-up scans showed significant tumor shrinkage. Emotionally, Angel moved from feeling like a passive victim of a random illness to an active participant in a targeted fight. The mutation analysis gave her cancer a name and, crucially, a specific adversary to tackle, replacing overwhelming fear with focused hope.